Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05282394 · ClinicalTrials.gov registry record · NA
Newborn Abdominal Massage to Prevent Hyperbilirubinemia
A NA study of Newborn Jaundice, sponsored by University of California, Davis.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05282394 is a NA study of Newborn Jaundice that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05282394, a NA study of Newborn Jaundice, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study will incorporate an intervention previously un-studied in the US healthcare setting for prevention of hyperbilirubinemia
Conditions Studied
Interventions
- PROCEDURE Abdominal massage
- OTHER Reading
Study Locations (1)
California
- University of California-Davis - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05282394
The ClinicalTrials.gov registry entry for NCT05282394 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Newborn Jaundice appearing as the primary indexed condition, and to 2 interventions - of which Abdominal massage is the first listed.
NCT05282394 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05282394 about?
NCT05282394 is a clinical study titled "Newborn Abdominal Massage to Prevent Hyperbilirubinemia". The proposed study will incorporate an intervention previously un-studied in the US healthcare setting for prevention of hyperbilirubinemia
What is the current status of trial NCT05282394?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-08-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05282394 study?
This clinical trial studies the following conditions: Newborn Jaundice.
What interventions are being tested in trial NCT05282394?
The interventions under investigation include: Abdominal massage (PROCEDURE), Reading (OTHER).
Who is sponsoring clinical trial NCT05282394?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05282394 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.